Ilex Medical (XTAE:ILX) ROCE % : 11.43% (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Ilex Medical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ilex Medical's annualized ROCE % for the quarter that ended in Mar. 2024 was 11.43%.

Ilex Medical ROCE % Historical Data

The historical data trend for Ilex Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ilex Medical ROCE % Chart

Ilex Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

23.88

35.00

45.35

21.15

10.10

Ilex Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															12.57	10.06	9.19	8.45	11.43

Ilex Medical ROCE % Calculation

Ilex Medical's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	71.272	/	( ( (899.181 - 225.825)	+	(1016.111 - 278.539) )	/ 2 )
	=	71.272	/	( (673.356	+	737.572)	/ 2 )
	=	71.272	/	705.464
	=	10.10 %

Ilex Medical's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	83.012	/	( ( (1016.111 - 278.539)	+	(999.48 - 285.005) )	/ 2 )
	=	83.012	/	( ( 737.572	+	714.475 )	/ 2 )
	=	83.012	/	726.0235
	=	11.43 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Ilex Medical (XTAE:ILX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ilex Medical ROCE % Related Terms

Thank you for viewing the detailed overview of Ilex Medical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ilex Medical (XTAE:ILX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ilex Medical Ltd (XTAE:ILX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kodak Building, 7 Hatnufa Street, PO Box 3156, Kiriat Arie Industrial Park, Petah Tikva, ISR, 4951025

Website

http://www.ilexmedical.com

Ilex Medical Ltd is an Israel based company engages in the marketing and distribution of diagnostic products and other medical laboratory information systems. It offers in-vitro diagnostic equipment, reagents, laboratory management software, blood bank diagnostic kits, and diagnostic support services to the healthcare sector in Israel.

Ilex Medical (XTAE:ILX) Headlines

No Headlines